Used in the synthesis of antibacterial agents, particularly in the development of oxazolidinone-class antibiotics. It serves as a chiral intermediate in the production of pharmaceuticals targeting drug-resistant bacterial infections, including those caused by MRSA and vancomycin-resistant enterococci. Its structural features support high potency and selectivity in inhibiting bacterial protein synthesis. Commonly employed in research and development for novel antimicrobial drugs with improved pharmacokinetic profiles.